FDA Inspection 1240546 — Beth Israel Deaconess Medical Center IRB
The FDA completed an inspection of Beth Israel Deaconess Medical Center IRB on May 8, 2024 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 8, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
IRB